+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
3SBio Inc - logo

3sbio is a biotechnology company that creates biopharmaceutical products. The company was incorporated in 2006, and is headquartered in Shenyang, China. It is a subsidiary of Decade Sunshine Limited. Their products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; and EPIAO, an injectable recombinant human erythropoietin for anemia associated with chronic kidney disease (CKD) and chemotherapy, as well as to reduce allogeneic blood transfusion in surgery patients. 3sbio sell their products to a range of countries including: Brazil, Colombia, Costa Rica ,Dominican Republic, Egypt, El Salvador, Guatemala, Laos, Mongolia, Myanmar, Pakistan, Paraguay, Philippines, Sri Lanka, Thailand and Trinidad and Tobago.

From
Erythropoietin Stimulating Agents Market 2024-2028 - Product Thumbnail Image

Erythropoietin Stimulating Agents Market 2024-2028

  • Report
  • October 2024
  • 137 Pages
  • Global
From
Erythropoietin (EPO) Market Report 2025 - Product Thumbnail Image

Erythropoietin (EPO) Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
From
Recombinant Uricase Market - Global Forecast 2025-2030 - Product Thumbnail Image

Recombinant Uricase Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
Regenerative Medicine for Cartilage Market Report 2025 - Product Thumbnail Image

Regenerative Medicine for Cartilage Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
From
Biologics Market Report 2025 - Product Thumbnail Image

Biologics Market Report 2025

  • Report
  • March 2025
  • 400 Pages
  • Global
From
From
End-Stage Renal Disease - Pipeline Insight, 2025 - Product Thumbnail Image

End-Stage Renal Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Macular Edema - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Macular Edema - Global Clinical Trials Review, 2024

  • Clinical Trials
  • November 2024
  • 893 Pages
  • Global
From
Chemotherapy-Induced Anemia Market Report 2025 - Product Thumbnail Image

Chemotherapy-Induced Anemia Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Anti-CD20 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD20 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Vaccine Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Vaccine Collaboration and Licensing Deals 2016-2025

  • Report
  • May 2025
  • 400 Pages
  • Global
From
Loading Indicator